Markets regulator Sebi is likely to reopen an insider trading case against Sun Pharmaceutical Industries as well as probe alleged lapses by some of its promoters and other entities in raising funds overseas, sources said.
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/2zAoo3L
Subscribe to:
Post Comments (Atom)
Swiggy IPO sees 35% subscription on Day 2
from Business News: Latest News Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/idlWNBM
-
A woman, in her early 20s, was stabbed to death by a man in southeast Delhi's Bhogal area on Friday evening, following which the accused...
-
Collecting Lego — yes, the plastic toys made of interlocking bricks that become cars and castles and robots —returned more than large stocks...
-
The Delhi High Court on Thursday dismissed the pleas of TTV Dhinakaran and VK Sasikala challenging the Election Commission's order grant...
No comments:
Post a Comment